These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8465887)

  • 21. The dexamethasone suppression test and negative symptoms of schizophrenia.
    McGauley GA; Aldridge CR; Fahy TA; Eastment C
    Acta Psychiatr Scand; 1989 Dec; 80(6):548-53. PubMed ID: 2618777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease.
    Miller AH; Sastry G; Speranza AJ; Lawlor BA; Mohs RC; Ryan TM; Gabriel SM; Serby M; Schmeidler J; Davis KL
    Am J Psychiatry; 1994 Feb; 151(2):267-70. PubMed ID: 8296902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone suppression test and suicide attempts in schizophrenic patients.
    Płocka-Lewandowska M; Araszkiewicz A; Rybakowski JK
    Eur Psychiatry; 2001 Nov; 16(7):428-31. PubMed ID: 11728857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone nonsuppression and short rapid eye movement latency in schizophrenia: markers of an affective diathesis?
    Goldman M; Tandon R; Taylor SF; DeQuardo JR; Shipley JE; Patel B; Reddig S; Jibson M
    Biol Psychiatry; 1996 Nov; 40(9):927-9. PubMed ID: 8896782
    [No Abstract]   [Full Text] [Related]  

  • 27. Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects.
    Monteleone P; Piccolo A; Martino M; Maj M
    Neuropsychobiology; 1994; 30(2-3):61-5. PubMed ID: 7800165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dexamethasone suppression test in organic affective syndrome.
    Evans DL; Nemeroff CB
    Am J Psychiatry; 1984 Nov; 141(11):1465-7. PubMed ID: 6496794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The DST and posttraumatic stress disorder.
    Kudler H; Davidson J; Meador K; Lipper S; Ely T
    Am J Psychiatry; 1987 Aug; 144(8):1068-71. PubMed ID: 3605429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia.
    Torres IJ; Keedy S; Marlow-O'Connor M; Beenken B; Goldman MB
    Neuropsychology; 2009 May; 23(3):307-14. PubMed ID: 19413445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia.
    Delva NJ; Crammer JL; Jarzylo SV; Lawson JS; Owen JA; Sribney M; Weir BJ; Yendt ER
    Biol Psychiatry; 1989 Dec; 26(8):781-93. PubMed ID: 2590692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological predictors of suicidality in schizophrenia.
    Lewis CF; Tandon R; Shipley JE; DeQuardo JR; Jibson M; Taylor SF; Goldman M
    Acta Psychiatr Scand; 1996 Dec; 94(6):416-20. PubMed ID: 9020992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and anxiety inventories, and the dexamethasone suppression test.
    Sangal R; Correa EI; DePaulo JR
    Biol Psychiatry; 1984 Aug; 19(8):1207-13. PubMed ID: 6498243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression].
    Rupprecht R; Barocka A; Pichl J
    Psychiatr Prax; 1988 Jul; 15(4):142-5. PubMed ID: 3406225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of the cortisol suppression index in depression.
    Bernstein JP; Chung SY
    J Clin Psychiatry; 1984 Oct; 45(10):433-6. PubMed ID: 6480569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal dexamethasone suppression test results in chronic schizophrenic patients.
    Dewan MJ; Pandurangi AK; Boucher ML; Levy BF; Major LF
    Am J Psychiatry; 1982 Nov; 139(11):1501-3. PubMed ID: 7137407
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical application of the dexamethasone suppression test in the differentiation of subgroups in anorexia nervosa].
    Hidalgo Rodrigo MI; Díaz González RJ; Cabranes Díaz JA; Hidalgo Rodrigo MA; Santiago Guervós M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(2):115-21. PubMed ID: 1651047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.